| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Panagiotis Korantzopoulos | Q88365196 |
| P2093 | author name string | Tong Liu | |
| Guangping Li | |||
| Lijian Li | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| Atrial Fibrillation | Q815819 | ||
| cardioversion | Q1729126 | ||
| P304 | page(s) | 1642-1648 | |
| P577 | publication date | 2007-04-02 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis | |
| P478 | volume | 49 |
| Q33758744 | A Potential Role of Esophageal Cancer Related Gene-4 for Atrial Fibrillation |
| Q34434368 | A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation |
| Q41955585 | A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation |
| Q37339307 | Antioxidant therapies for the management of atrial fibrillation |
| Q85188354 | Apelin Plasma Levels Predict Arrhythmia Recurrence in Patients with Persistent Atrial Fibrillation |
| Q45091973 | Assessment of interleukin-1 gene cluster polymorphisms in lone atrial fibrillation: new insight into the role of inflammation in atrial fibrillation |
| Q85681378 | Assessment of left atrial volume and function in patients with psoriasis by using real time three-dimensional echocardiography |
| Q52975445 | Assessment of radiological techniques application possibility for non-invasive diagnostics of latent inflammatory processes in myocardium in patients with atrial fibrillation. |
| Q31134080 | Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction |
| Q38639060 | Association between Serum TNF-α Levels and Recurrent Spontaneous Miscarriage: A Meta-analysis |
| Q89845657 | Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies |
| Q64116453 | Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis |
| Q35605552 | Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression |
| Q36069585 | Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis |
| Q37942600 | Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials |
| Q37115344 | C-Reactive Protein and The Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis |
| Q38789345 | C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study. |
| Q37495903 | Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients |
| Q35034986 | Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis |
| Q28069406 | Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis |
| Q33724642 | Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial. |
| Q39300599 | Commentary on: Pericardial Fat is Independently Associated with Human Atrial Fibrillation by Al Chekakie et al. |
| Q53276190 | Deferoxamine therapy for intracerebral hemorrhage: A systematic review. |
| Q38234313 | Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies |
| Q41686277 | Discordant Relationships between Systemic Inflammatory Markers and Burden of Oxidative Stress in Patients with Atrial Fibrillation |
| Q35664577 | Efficiency and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibody on hypercholesterolemia: a meta-analysis of 20 randomized controlled trials |
| Q51104775 | Elevated calprotectin in patients with atrial fibrillation with and without heart failure. |
| Q38294119 | Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range |
| Q52744483 | Evaluation of ventricular repolarization features with novel electrocardiographic parameters (Tp-e, Tp-e/QT) in patients with psoriasis. |
| Q34507611 | Family history as a risk factor for recurrent hospitalization for lone atrial fibrillation: a nationwide family study in Sweden |
| Q35103683 | Fast-track program vs traditional care in surgery for gastric cancer |
| Q37117179 | Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer |
| Q35756480 | High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial |
| Q82526387 | High‐Sensitivity C‐Reactive Protein as a Predictor of Atrial Fibrillation Recurrence after Primary Circumferential Pulmonary Vein Isolation |
| Q43195079 | Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence |
| Q33693147 | Impact of C-reactive protein on in-stent restenosis: a meta-analysis |
| Q44698193 | Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis |
| Q55395199 | Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation. |
| Q85219264 | Improved Endothelial Function in Patients with Atrial Fibrillation through Maintenance of Sinus Rhythm by Successful Catheter Ablation |
| Q41150203 | Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. |
| Q39418050 | Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients |
| Q59034735 | Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients |
| Q57179188 | Inflammation and atrial fibrillation: A comprehensive review |
| Q85016981 | Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease |
| Q37064322 | Is CaMKII a link between inflammation and hypertrophy in heart? |
| Q44176871 | Left ventricular ejection fraction and left atrium diameter related to new-onset atrial fibrillation following acute myocardial infarction: a systematic review and meta-analysis. |
| Q30409016 | Lone atrial fibrillation: where are we now? |
| Q27023057 | Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections |
| Q30248327 | Meta-analysis of Vitamin D Deficiency and Risk of Atrial Fibrillation. |
| Q90571471 | Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project |
| Q34603226 | Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes |
| Q34359362 | Obesity and atrial fibrillation |
| Q30663685 | Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference |
| Q57496719 | Plasma markers of myocardial inflammation at isolated atrial fibrillation |
| Q37248230 | Pleiotropic effects of statins in atrial fibrillation patients: the evidence |
| Q26750083 | Prediction of atrial fibrillation development and progression: Current perspectives |
| Q36611458 | Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q37638445 | Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance |
| Q41102423 | Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy |
| Q48345203 | Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery |
| Q50554433 | Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. |
| Q34371293 | Quality of systematic reviews of observational nontherapeutic studies |
| Q48281906 | Red blood cell distribution width as a predictor of atrial fibrillation. |
| Q30249311 | Relation of N-terminal pro-brain natriuretic peptide and new-onset atrial fibrillation in patients with acute coronary syndrome: a systematic review and meta-analysis. |
| Q33573035 | Relation of multiple inflammatory biomarkers to incident atrial fibrillation |
| Q35575045 | Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community |
| Q36688872 | Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation |
| Q34407849 | Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome |
| Q36178661 | Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study. |
| Q35815364 | Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study |
| Q37596189 | Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease |
| Q38732470 | Risk of incident atrial fibrillation in gout: a cohort study. |
| Q38675960 | Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| Q40961876 | Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation |
| Q47127645 | Scar homogenization in AF ablation: Evolution and practice |
| Q36299330 | Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression |
| Q36321530 | Serum levels of nicotinamide-adenine dinucleotide phosphate oxidase 4 are associated with non-valvular atrial fibrillation |
| Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
| Q33984012 | Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score |
| Q37038371 | Statins and polyunsaturated fatty acids for treatment of atrial fibrillation |
| Q37293140 | Structural remodeling in atrial fibrillation. |
| Q37602866 | Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. |
| Q92434811 | The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes |
| Q26742118 | The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror |
| Q58597887 | The association of high D-dimer level with high risk of ischemic stroke in nonvalvular atrial fibrillation patients: A retrospective study |
| Q89823179 | The effect of thiol-disulfide homeostasis in patients undergoing on-pump coronary artery bypass grafting |
| Q42868308 | The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: A meta-analysis |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q38167672 | The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy |
| Q36337187 | Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis |
| Q35926637 | Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial |
| Q37846370 | Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. |
| Q37868371 | Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. |
Search more.